Silk Road Medical (NASDAQ:SILK) PT Lowered to $55.00

Silk Road Medical (NASDAQ:SILK – Get Rating) had its target price decreased by Argus from $70.00 to $55.00 in a research report issued on Monday, The Fly reports. Argus’ price target points to a potential upside of 74.49% from the stock’s current price. SILK has been the topic of several other reports. Piper Sandler decreased […]

Related Keywords

Richard Ruedy ,Lucasw Buchanan ,Stifel Nicolaus ,Piper Sandler ,Pricet Rowe Associates Inc ,Wolfe Research ,Securities Exchange Commission ,Mengis Capital Management Inc ,Nasdaq ,Wells Fargo Company ,Financial Services Group Inc ,Citigroup ,Silk Road Medical ,Get Rating ,Road Medical ,Silk Road ,Exchange Commission ,Services Group ,Mengis Capital Management ,Capital Management ,Silk Road Medical Daily ,Nasdaq Silk ,Silk ,Medical ,Lower Price Target ,Argus ,